BSECompany Update1d ago · 26 Oct 2026, 07:42 pm
Audio recording of the Earnings Call dated October 26, 2026
Aptus Pharma Ltd · 544529
✦ AI SummaryResults
Aptus Pharma Ltd has uploaded the audio recording of its earnings call for the half year ended September 30, 2026, on its website. The company has complied with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
0507c4a7-1631-4d68-9c01-0bd305a082ee.pdf
View document text
APTUS PHARMA LIMITED
Date: 26th October 2026
The BSE Ltd
Phiroze Jeejeebhoy Tower,
Dalal Street,
Mumbai – 400001
SECURITY CODE: 544529
SCRIPT SYMBOL: APPL
Subject: Audio recording of the Earnings Call dated October 26, 2026
Dear Sir/Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended and in furtherance of our intimation dated
October 21, 2026, we hereby confirm that the audio recording of the earnings call, conducted on
October 26, 2026 for the half year ended September 30, 2026, has been uploaded on the website of
the Company at https://aptus-pharma.com/concall-aptus-pharma-ltd/
Kindly take the above information on record.
Thanking you,
Yours faithfully,
For Aptus Pharma Limited
Tejash Hathi
Managing Director
DIN: 03151221
Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi,
Ahmedabad, Gujarat – 382427, India
Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com
CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM